{
    "clinical_study": {
        "@rank": "19945", 
        "acronym": "HAPPIER", 
        "arm_group": [
            {
                "arm_group_label": "ischaemic cardiomyopathy", 
                "description": "EP (Electrophysiology) study,magnetic resonance with LGE (Late gadolinium enhancement), ICD implantation"
            }, 
            {
                "arm_group_label": "non-ischaemic cardiomyopathy", 
                "description": "EP study,magnetic resonance imaging with LGE, ICD implantation"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is further risk stratification of patients receiving implantable\n      cardioverter-defibrillator in primary prevention of sudden cardiac death."
        }, 
        "brief_title": "Profitability Trial in Primary Preventive Implantable Cardioverter-defibrillator Recipients", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ischaemic Cardiomyopathy", 
            "Non-ischaemic Cardiomyopathy"
        ], 
        "condition_browse": {
            "mesh_term": "Cardiomyopathies"
        }, 
        "detailed_description": {
            "textblock": "Current criteria for risk stratification of patients in risk of sudden cardiac death are\n      mainly based on left ventricular ejection fraction and NYHA class. This criteria are too\n      robust, approximately 2/3 of ICD recipients do not profit from this treatment in the\n      following 5 years, especially those with non-ischaemic cardiomyopathy. We plan to\n      sub-stratify this group of patients with both ischaemic and non-ischaemic cardiomyopathy by:\n      non-linear heart rate variability analysis, microvolt T-wave alternans, QRT-T angle and\n      character and amount of left ventricular scarring assessed by magnetic resonance imaging.\n      Pre-implantation values will be correlated with numbers and character of ICD therapy (both\n      anti-tachycardial pacing and ICD discharge). The results may allow to decrease the number of\n      patients, who do not profit from ICD treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  LVD (left ventricular dysfunction) d/t MI (Myocardial infarction), LVEF 30% or less,\n             NYHA (New York Heart association class) II, III\n\n          -  LVD d/t MI, LVEF 30% to 35%, NYHA II, III\n\n          -  LVD d/t MI, LVEF 30% to 40%, NSVT, positive EP study\n\n          -  LVD d/t MI, LVEF 30% or less, NYHA I\n\n          -  NICM (non-ischaemic cardiomyopathy), LVEF 30% or less, NYHA II, III\n\n          -  NICM, LVEF 30% to 35%, NYHA II, III\n\n          -  NICM, LVEF 30% or less, NYHA I\n\n          -  signed informed consent\n\n        Exclusion Criteria:\n\n          -  metallic foreign body (metal sliver) in their eye, or who have an aneurysm clip in\n             their brain, cannot have an MRI scan since the magnetic field may dislodge the metal\n\n          -  severe claustrophobia may not be able to tolerate an MRI scan\n\n          -  heart rhythm device in place before enrollment\n\n          -  atrial fibrillation in time of enrollment\n\n          -  ICD implantation indicated from secondary prevention of SCD (sudden cardiac death)\n\n          -  NYHA or CCS class IV\n\n          -  PCI or CABG in last 3 months\n\n          -  CMP/TIA in last 3 months\n\n          -  syncope of unknown etiology"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Heart-failure clinic,primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "360", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823211", 
            "org_study_id": "FNO-KVO-2", 
            "secondary_id": "Plasek680-2"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ICD (Implantable cardioverter-defibrillator)", 
            "Heart rate variability", 
            "MTWA (Microvolt T-alternans)", 
            "Magnetic resonance imaging (MRI)"
        ], 
        "lastchanged_date": "September 27, 2013", 
        "link": {
            "description": "Trial database", 
            "url": "http://happiertrial.org"
        }, 
        "location": [
            {
                "contact": {
                    "email": "jspinar@fnbrno.cz", 
                    "last_name": "Jindrich Spinar, MD,PhD,FESC", 
                    "phone": "+420 532 23 2601"
                }, 
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic", 
                        "zip": "62500"
                    }, 
                    "name": "Brno University Hospital"
                }, 
                "investigator": {
                    "last_name": "Lubos Krivan, MD,PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "1.interna@fnol.cz", 
                    "last_name": "Milos Taborsky, MD,PhD,FESC,MBA", 
                    "phone": "+420 588 443 201"
                }, 
                "facility": {
                    "address": {
                        "city": "Olomouc", 
                        "country": "Czech Republic", 
                        "zip": "775 20"
                    }, 
                    "name": "University Hospital Olomouc"
                }, 
                "investigator": {
                    "last_name": "Ondrej Moravec, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vaclav.prochazka@fno.cz", 
                    "last_name": "Vaclav Prochazka, MD,PhD,MSc", 
                    "phone": "+420597372510"
                }, 
                "facility": {
                    "address": {
                        "city": "Ostrava", 
                        "country": "Czech Republic", 
                        "zip": "70852"
                    }, 
                    "name": "University Hospital Ostrava"
                }, 
                "investigator": [
                    {
                        "last_name": "Jiri Plasek, MD,PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "David Sipula, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_groups": "2", 
        "official_title": "Heart Rate Variability, Microvolt T-wave Alternans and Cardiac Magnetic Resonance Imaging Analysis in Primary Preventive ImplantablE Cardioverter-defibrillator Recipients Profitability Trial - HAPPIER Trial", 
        "other_outcome": [
            {
                "description": "mortality from both cardiovascular and non-cardiovascular cause", 
                "measure": "all-cause mortality", 
                "safety_issue": "No", 
                "time_frame": "36-months"
            }, 
            {
                "description": "death from strictly cardiovascular cause", 
                "measure": "Cardiovascular mortality", 
                "safety_issue": "No", 
                "time_frame": "36-months"
            }
        ], 
        "overall_contact": {
            "email": "vaclav.prochazka@fno.cz", 
            "last_name": "Vaclav Prochazka, MD,PhD,MSc", 
            "phone": "+420597372510"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Cardiology,University hospital Ostrava", 
                "last_name": "Jiri Plasek, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Department of Cardiology,University Hospital Olomouc", 
                "last_name": "Milos Taborsky, MD, PhD, FESC", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Cardiology,University Hospital Brno-Bohunice", 
                "last_name": "Lubos Krivan, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Cardiology,University Hospital Olomouc", 
                "last_name": "Ondrej Moravec, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Czech Republic: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "ventricular tachycardia equal or > 250/min,ventricular fibrillation, arrhythmic storm", 
            "measure": "ventricular tachyarrhytmia", 
            "safety_issue": "No", 
            "time_frame": "36 months"
        }, 
        "reference": {
            "PMID": "15566580", 
            "citation": "Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Crit Care. 2004 Dec;8(6):R367-84. Epub 2004 Sep 22. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823211"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Ostrava", 
            "investigator_full_name": "Vaclav Prochazka, MD, PhD. MSc", 
            "investigator_title": "MD,PhD,MSc", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "death in 24-hours after symptom onset", 
            "measure": "sudden cardiac death", 
            "safety_issue": "No", 
            "time_frame": "36-months"
        }, 
        "source": "University Hospital Ostrava", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University Hospital Olomouc", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Brno University Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Hospital Ostrava", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "36 Months", 
        "verification_date": "September 2013"
    }
}